Towards Healthcare
Advanced Therapies in Biopharmaceutical Medicine Market Trends and Companies

Advanced Therapies in Biopharmaceutical Medicine Market is Driving Personalized Solutions

The advanced therapies in biopharmaceutical medicine market is expanding due to increasing diseases as well as growing gene editing therapies. North America led the market due to the presence of a well-developed healthcare sector.

  • Insight Code: 5732
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The advanced therapies in biopharmaceutical medicine market is emerging rapidly, driven by tech innovation and shifting patient needs from 2025 to 2034.

North America is currently leading the advanced therapies in biopharmaceutical medicine market due to a well-developed healthcare sector.

The advanced therapies in biopharmaceutical medicine market include 6 segments such as therapy type, application, product type, distribution channel, end user, and region.

Some key players include Pfizer Inc., Johnson & Johnson, AbbVie Inc., and F. Hoffmann-La Roche Ltd.

Key trends include growth in collaborations and innovation in cell and exosome therapies.

The types of therapies included in advanced therapy medicinal products (ATMPs) are cell therapy, gene therapy, tissue engineering, and their hybrid forms.

Growing diseases are the factor that drives the market.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.